Yields Finally Bit Back

Welcome to the Daily Rip market recap. The market finally took a breather Friday after a record-setting run, with tech stocks cooling off and bond yields pushing higher. Let’s break down what moved the tape and what to watch next.

I.. But Friday saw a pullback as inflation data and rising Treasury yields rattled investors. The 10-year Treasury yield climbed above four point six percent, its highest in a year, while the 30-year yield topped five point one percent, nearing 2023 highs.

This surge in yields is a sign that markets are starting to price in the possibility of more Federal Reserve rate hikes, not cuts, as inflation remains stubbornly high. Energy prices added fuel to the fire, with oil continuing to climb amid geopolitical tensions and no resolution in sight for the Iran conflict. This combination of rising yields, hot inflation prints, and geopolitical uncertainty tightened valuation multiples, especially in growth-heavy sectors like tech.

Speaking of tech, Nvidia took a hit Friday, sliding over four percent to around two hundred twenty-five dollars. The chip giant was in focus after the Trump-Xi summit failed to ease restrictions on chip exports to China. Despite CEO Jensen Huang’s presence in the delegation, no breakthrough emerged, leaving investors concerned about continued policy friction.

I. demand and dip buying to support the stock. I.

infrastructure, dropped sharply—down twenty-two percent after reporting a quarterly loss of twelve point three million dollars, or eight cents per share. Revenue was modest at just over five hundred thousand dollars, but the company announced a massive four hundred million dollar capital raise at twenty-one dollars per share, with warrants at twenty-six dollars and fifteen cents. This financing split traders between viewing it as a validation of growth plans or a dilution risk.

the company's CFO also announced plans to retire this year, adding to uncertainty. The key debate: can the company's revenue ramp justify the expanded share count? The Stocktwits crowd remains engaged but cautious.

On the broader market front, a few notable movers stood out Friday. I. testing momentum, while SolarEdge jumped twenty-three percent on better-than-expected first-quarter revenue.

Tonix Pharmaceuticals climbed almost twelve percent amid renewed chatter about fibromyalgia treatment approval. Venture Global also gained nine percent after earnings before interest, taxes, depreciation, and amortization guidance more than doubled. Meanwhile, Microsoft popped three and a half percent following news that activist investor Bill Ackman took a new stake in the company.

On the downside, B. Riley slid three and a half percent amid persistent short-interest pressure, and Caterpillar dropped three and a half percent after insider selling weighed on sentiment. Back to macro, silver emerged as a key inflation hedge amid the bond selloff.

The iShares Silver Trust ETF fell eight and a half percent, reflecting debate over whether precious metals can hold up against rising yields and inflation pressures. Traders are watching silver closely as a stress-test asset in this volatile environment. In biotech, Candel Therapeutics dipped one and a half percent despite positive Phase 3 prostate cancer data showing a thirty-nine percent improvement in disease-specific outcomes.

The market seemed to have priced in much of the excitement already. Bulls highlight the potential for the first new localized prostate cancer therapy in over two decades, but risks remain around FDA timing and funding. I.

demand and China exposure. Watch Treasury yields closely for signs of further Fed tightening pressure. Also, monitor energy prices and inflation data, which will continue to shape market sentiment.

That’s your Daily Rip market recap. Stay sharp, and we’ll catch you next time on LazyListen.